BRPI1008359A2 - método para produzir partículas de medicamento de tamanho de partícula pequeno - Google Patents

método para produzir partículas de medicamento de tamanho de partícula pequeno

Info

Publication number
BRPI1008359A2
BRPI1008359A2 BRPI1008359A BRPI1008359A BRPI1008359A2 BR PI1008359 A2 BRPI1008359 A2 BR PI1008359A2 BR PI1008359 A BRPI1008359 A BR PI1008359A BR PI1008359 A BRPI1008359 A BR PI1008359A BR PI1008359 A2 BRPI1008359 A2 BR PI1008359A2
Authority
BR
Brazil
Prior art keywords
particle size
small particle
producing small
medicine particles
size medicine
Prior art date
Application number
BRPI1008359A
Other languages
English (en)
Inventor
Akif Emre Türeli
Bernd Baumstümmler
Bernd Penth
Peter Langguth
Original Assignee
Mjr Pharmajet Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mjr Pharmajet Gmbh filed Critical Mjr Pharmajet Gmbh
Publication of BRPI1008359A2 publication Critical patent/BRPI1008359A2/pt
Publication of BRPI1008359B1 publication Critical patent/BRPI1008359B1/pt
Publication of BRPI1008359B8 publication Critical patent/BRPI1008359B8/pt

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605Excipients; Inactive ingredients
    • A61K9/1629Organic macromolecular compounds
    • A61K9/1635Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605Excipients; Inactive ingredients
    • A61K9/1629Organic macromolecular compounds
    • A61K9/1652Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • A61P5/24Drugs for disorders of the endocrine system of the sex hormones

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Emergency Medicine (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Physical Or Chemical Processes And Apparatus (AREA)
BRPI1008359A 2009-02-11 2010-02-11 método para produzir partículas de medicamento de tamanho de partícula pequeno BRPI1008359B8 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE102009008478A DE102009008478A1 (de) 2009-02-11 2009-02-11 Vorrichtung und Verfahren zur Herstellung pharmazeutisch hochfeiner Partikel sowie zur Beschichtung solcher Partikel in Mikroreaktoren
DE102009008478.9 2009-02-11
PCT/DE2010/075015 WO2010091683A2 (de) 2009-02-11 2010-02-11 Vorrichtung und verfahren zur herstellung pharmazeutisch hochfeiner partikel sowie zur beschichtung solcher partikel in mikroreaktoren

Publications (3)

Publication Number Publication Date
BRPI1008359A2 true BRPI1008359A2 (pt) 2016-02-23
BRPI1008359B1 BRPI1008359B1 (pt) 2021-01-12
BRPI1008359B8 BRPI1008359B8 (pt) 2021-05-25

Family

ID=42338614

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI1008359A BRPI1008359B8 (pt) 2009-02-11 2010-02-11 método para produzir partículas de medicamento de tamanho de partícula pequeno

Country Status (9)

Country Link
US (1) US8697131B2 (pt)
EP (1) EP2395978B1 (pt)
JP (1) JP5624059B2 (pt)
KR (1) KR101515263B1 (pt)
CN (2) CN105125502A (pt)
BR (1) BRPI1008359B8 (pt)
CA (1) CA2751625C (pt)
DE (1) DE102009008478A1 (pt)
WO (1) WO2010091683A2 (pt)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ602674A (en) 2010-03-22 2013-10-25 Mjr Pharmjet Gmbh Method and device for producing microparticles or nanoparticles
US20120167410A1 (en) * 2010-12-21 2012-07-05 Basf Se Spray drying techniques
CN103127889B (zh) * 2011-11-29 2016-01-13 北京大学 制备功能纳米粒子的减压诱导微射流混合法及其应用
BR112015024868A2 (pt) 2013-03-28 2017-07-18 Instillo Gmbh método para produzir dispersões e matérias sólidas através de precipitação, coprecipitação e processo de auto-organização controlados e método para produzir dispersões e matérias sólidas através de precipitação controlada, coprecipitação e processo de auto-organização em um reator de microjato
US9468626B2 (en) 2014-03-13 2016-10-18 Chiesi Farmaceutici S.P.A. Melatonin-based formulations for parenteral administration
CA2947486C (en) 2014-05-19 2023-09-26 The Medicines Company Clevidipine nanoparticles and pharmaceutical compositions thereof
CN104226211B (zh) * 2014-09-17 2018-08-10 天津春发生物科技集团有限公司 一种生物-喷雾干燥法制备香精微胶囊的方法
DE202015100863U1 (de) 2015-02-23 2016-05-30 Care Connection Gmbh Behälter zur Applikation einer Tannin-enthaltenden Deodorant- oder Antitranspirantzusammensetzung
DE202015100862U1 (de) 2015-02-23 2016-05-30 Care Connection Gmbh Tannin-Nanopartikel enthaltende Deodorant- oder Antitranspirantzusammensetzung
EP3270891A1 (en) * 2015-03-17 2018-01-24 Leon-Nanodrugs GmbH Nanoparticles comprising a stabilized boronic acid compound
DE102016101232A1 (de) 2016-01-25 2017-07-27 Instillo Gmbh Verfahren zum Herstellen von Emulsionen
DE102017110292B4 (de) 2017-05-11 2020-06-10 Instillo Gmbh Verfahren zum Herstellen von Reaktionsprodukten
WO2019166322A1 (en) 2018-03-02 2019-09-06 Chiesi Farmaceutici S.P.A. A pharmaceutical formulation for intraduodenal administration comprising melevodopa and carbidopa
CN110385124B (zh) * 2018-04-16 2021-01-26 浙江大学 一种通过分段反应制备MnOx-CeO2混合氧化物催化剂的方法
US10912326B2 (en) 2018-08-22 2021-02-09 Rachelle MACSWEENEY Nanoformulations containing encapsulted omega-3 fatty acids
DE102019112382A1 (de) 2019-05-13 2020-11-19 MyBiotech GmbH Verwendung eines MikroJet-Reaktors zum Zellaufschluss
CA3141534A1 (en) 2019-05-23 2020-11-26 Helm Ag Nanoparticles comprising enzalutamide
EP3795646A1 (de) 2019-12-19 2021-03-24 nanoSaar Lab GmbH Farb- und füllstoffpasten unter verwendung anorganischer partikel mit beschichteter oberfläche als spacer
EP3915544A1 (en) 2020-05-25 2021-12-01 Leon-Nanodrugs GmbH Method for producing a liposome dispersion
EP4008322B1 (de) 2020-05-25 2024-11-27 leon-nanodrugs GmbH Lecithin-partikel im nanometer bereich als wirkstoffträger zur parenteralen verabreichung
EP3915673A1 (de) 2020-05-25 2021-12-01 Leon-Nanodrugs GmbH Verfahren zur überprüfung der funktionsfähigkeit einer anlage zur herstellung von nanopartikeln durch gezielte fällung aus übersättigten lösungen
EP3915546A1 (de) * 2020-05-25 2021-12-01 Leon-Nanodrugs GmbH Verwendung von säure als lösungsmittel für präzipitationen
AU2022270938A1 (en) 2021-05-05 2023-11-02 Leon-Nanodrugs Gmbh Methods for producing nanoparticle dispersions
EP4163006B8 (en) 2021-10-11 2024-03-20 leon-nanodrugs GmbH Methods for validating an apparatus for producing nanoparticles
EP4198105A1 (en) 2021-12-16 2023-06-21 Seaborough IP I B.V. Microjet reactor based synthesis of nanophosphors
CN114669085B (zh) * 2022-01-28 2024-05-31 南京宁源科生物技术有限公司 一种药用颗粒的有机溶剂去除装置
WO2025228668A1 (en) 2024-05-03 2025-11-06 Leon-Nanodrugs Gmbh Method for manufacturing lipid nanoparticles

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2078447T3 (es) 1990-06-15 1995-12-16 Merck & Co Inc Un procedimiento de cristalizacion para mejorar la estructura y el tamaño de los cristales.
DE19617085A1 (de) * 1996-04-29 1997-10-30 Bayer Ag Verfahren zur Herstellung von feinstteiligen Kristallisationsprodukten
GB9828721D0 (en) * 1998-12-24 1999-02-17 Glaxo Group Ltd Novel apparatus and process
JP2002540930A (ja) * 1999-04-08 2002-12-03 ペント ベルント 化学的プロセスおよび物理的プロセスを実施するための方法および装置
YU34501A (sh) 2000-05-26 2003-10-31 Pfizer Products Inc. Postupak reaktivne kristalizacije radi povećanja veličine čestica
NZ526608A (en) 2000-12-22 2006-06-30 Baxter Int Method for preparing submicron particle suspensions
US6884436B2 (en) 2000-12-22 2005-04-26 Baxter International Inc. Method for preparing submicron particle suspensions
DE10214031A1 (de) 2002-03-27 2004-02-19 Pharmatech Gmbh Verfahren zur Herstellung und Anwendung von Mikro- und Nanoteilchen durch aufbauende Mikronisation
US7041144B2 (en) * 2003-03-04 2006-05-09 Five Star Technologies, Inc. Hydrodynamic cavitation crystallization process
US20060151899A1 (en) 2003-08-06 2006-07-13 Akira Kato Process for producing drug ultramicroparticle and apparatus therefor
TWI371274B (en) * 2003-10-23 2012-09-01 Bristol Myers Squibb Co Process for making sterile aripiprazole of desired mean particle size
DE102005048201A1 (de) 2004-10-11 2006-04-20 Penth, Bernd, Dr. Kontinuierliche Fällung von nanoskaligen Produkten in Mikroreaktoren
DE102005011786A1 (de) 2005-03-11 2006-09-14 Pharmasol Gmbh Verfahren zur Herstellung ultrafeiner Submicron-Suspensionen
DE102005017777A1 (de) 2005-04-13 2006-10-19 Pharmasol Gmbh Verfahren zur schonenden Herstellung von hochfeinen Partikelsuspensionen
DE102005048021B3 (de) 2005-10-06 2007-04-12 Abb Patent Gmbh Lokal bedienbares Automatisierungsgerät
DE102005053862A1 (de) 2005-11-04 2007-05-10 Pharmasol Gmbh Verfahren und Vorrichtung zur Herstellung hochfeiner Partikel sowie zur Beschichtung solcher Partikel

Also Published As

Publication number Publication date
EP2395978B1 (de) 2015-05-27
CA2751625A1 (en) 2010-08-19
CN102316853A (zh) 2012-01-11
DE102009008478A1 (de) 2010-08-19
CN105125502A (zh) 2015-12-09
BRPI1008359B1 (pt) 2021-01-12
KR101515263B1 (ko) 2015-04-24
KR20110118714A (ko) 2011-10-31
US20110294770A1 (en) 2011-12-01
CA2751625C (en) 2014-10-14
EP2395978A2 (de) 2011-12-21
JP5624059B2 (ja) 2014-11-12
US8697131B2 (en) 2014-04-15
JP2012517403A (ja) 2012-08-02
WO2010091683A2 (de) 2010-08-19
WO2010091683A3 (de) 2010-10-21
BRPI1008359B8 (pt) 2021-05-25

Similar Documents

Publication Publication Date Title
BRPI1008359A2 (pt) método para produzir partículas de medicamento de tamanho de partícula pequeno
EP2545104A4 (en) PARTICLES AND METHOD FOR THE PRODUCTION THEREOF
CO6930351A2 (es) Línea de proceso para la producción de particulas criodesecadas
CO6930352A2 (es) Línea de proceso para la producción de partículas criodesecadas
PL2736837T3 (pl) Sposób produkcji nanodrutów krzemowych
SG11201400744XA (en) Self-assembled nano-structure particle and method for preparing
ZA201403625B (en) Method for manufacturing spheroidal alumina particles
SG2014004741A (en) Particle breakup size apparatus
BR112013008062A2 (pt) métodos para produzir partículas de réplicon de bunyavírus
PT2686026T (pt) Partículas compósitas microestruturadas
GB201109319D0 (en) Fine particles
ZA201206091B (en) Methods for producing photosensitive microparticles
EP2699670A4 (en) PARTICLES SYNTHETIZED FROM CELLS
ZA201309469B (en) Process for producing inorganic particulate material
EP2610338A4 (en) PROCESS FOR PRODUCTION OF SUBSTANCE
EP2707480A4 (en) PSEUDOVIRAL PARTICLES (VLPs) AND PREPARATION METHOD THEREOF
SG11201400287XA (en) Methods for producing biocompatible materials
EP2919898A4 (en) PROCESS FOR PRODUCTION OF PARTICLES AND APPARATUS THEREFOR
SMT202100198T1 (it) Metodo e apparecchio per la preparazione di particelle di idrossodo di calcio
SI2739725T1 (sl) Postopek za čiščenje od virusov-podobnih delcev
PT2570120T (pt) Partículas revestidas e processo de produção de partículas revestidas
ZA201404277B (en) Process for making magnolol and derivatives thereof
PT2550305T (pt) Processo contínuo para preparar partículas de polifluoroacrilato
EP2835686A4 (en) FINE ELECTRETIC PARTICLES AND METHOD FOR THE PRODUCTION THEREOF
SG11201401251TA (en) Slurry and method for producing slurry

Legal Events

Date Code Title Description
B25D Requested change of name of applicant approved

Owner name: INSTILLO GMBH (DE)

B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]
B06T Formal requirements before examination [chapter 6.20 patent gazette]
B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 12/01/2021, OBSERVADAS AS CONDICOES LEGAIS.

B16C Correction of notification of the grant [chapter 16.3 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 11/02/2010 OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF